New York, NYNCT05390827Now EnrollingIRB Ready

Solid Tumor Clinical Trial in New York, NY

Access cutting-edge solid tumor treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Memorial Sloan Kettering Cancer Center

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access solid tumor specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related solid tumor treatment provided free

Apply for This New York Location

Check if you qualify for this solid tumor clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Solid Tumor Study in New York

The purpose of this study is to develop a secure method of collecting physiologic information from patients with cancer. The researchers will use this information to learn more about how physiologic data may relate to cancer diagnosis and response to treatment, and to identify factors that may lead to higher or lower risk of cancer.

Sponsor: Memorial Sloan Kettering Cancer Center

Who Can Participate

Inclusion Criteria

Project 1: HealthKit
Individuals who meet at least one of the following criteria:
Diagnosis of new onset early-stage (I-III), low-grade (I-II), or locally advanced solid tumor
Historical diagnosis of primary invasive solid tumor
Diagnosis of metastatic (stage IV) or high-grade (III-IV) disease
Enrolled onto an investigational trial in the EDD Service
Seen in the MSK UCC from 2021 and onwards
Completion of Survivorship Patient Self-Assessment
Adult without a history of cancer \<50 years of age
Adult without a history of cancer ≥ 50 years of age
≥18 years old
Own an Apple iPhone with valid iOS operating software
Have a registered MSK MyChart account
Self-reported "very well" comprehension of written and verbal English language
Willing and able to provide informed consent and HIPAA authorization for the release of personal health information Project 2: DigIT-Ex Individuals who meet one of the following criteria:
Patients at MSK who are:
Scheduled to undergo any type of BMT (Cohort 1)
Diagnosed with new onset AML and scheduled to initiate antineoplastic therapy (Cohort 2)
Scheduled to undergo any surgery for prostate cancer (Cohort 3)
Scheduled to undergo any lung cancer surgery (Cohort 4)
Scheduled to undergo TNT for locally advanced rectal cancer (Cohort 5)
Scheduled to initiate androgen deprivation therapy for at least 12 months and has one of the following prostate cancer diagnoses (Cohort 6):
High risk/very high localized, locally advanced,
Biochemically recurrent prostate cancer
Treatment naïve, low-volume metastatic prostate cancer
Scheduled Scheduled to undergo chemotherapy for metastatic pancreatic cancer (Cohort 7)
Receiving outpatient care at Memorial Sloan Kettering Cancer Center (MSK)(Cohort 10)
Diagnosed with metastatic cancer to bone (Cohort 10)
Scheduled for non-emergent orthopaedic surgery to stabilize lower-extremity bone metastases (Cohort 10)
Able to undergo at least 5 consecutive days of preoperative monitoring prior to surgery (Cohort 10)
Have had a CT scan including the L3 vertebral level within 3 months before surgery (used to assess skeletal muscle mass and sarcopenia) (Cohort 10)
Have a ≥50% predicted likelihood of 6-month postoperative survival, as estimated by the PATHFx clinical decision-support tool (Cohort 10
Individuals without cancer \<50 years of age (Cohort 8)
Individuals without cancer ≥50 years of age (Cohort 9)
18 to 90 years old at the time of consent
Willing and able to download the Withings Health Mate app onto their personal mobile device
Willing to provide mobile digital physiological data for a period of at least six months to a maximum of one year following consent
Willing to provide informed consent

Exclusion Criteria

Project 1: HealthKit
Unable or unwilling to successfully export and /or share physiological data Project 2: DigIT-Ex
Unable or unwilling to appropriately use digital platforms or devices
Require a wheelchair for ambulation (Cohort 10)
Are undergoing stabilization surgery for a primary bone tumor (rather than metastatic disease) (Cohort 10)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT05390827) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Solid Tumor Treatment Options in New York, NY

If you're searching for solid tumor treatment options in New York, NY, this clinical trial (NCT05390827) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all solid tumor clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in New York, NY

See all advanced solid tumors clinical trials recruiting in New York — not just this study.

Browse Advanced Solid Tumors Trials in New York →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY